Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Benjamin Bonsang"'
Autor:
Romain-David Seban, Camille Vermersch, Laurence Champion, Benjamin Bonsang, Anissa Roger, Jerome Ghidaglia
Publikováno v:
Diagnostics, Vol 11, Iss 5, p 747 (2021)
Early detection of immune-related adverse events (irAEs) with immune checkpoint inhibitors (ICIs) is crucial, particularly when these are likely to mimic tumor progression, as well as sarcoid-like reactions. Here, we report the case of a 68-year woma
Externí odkaz:
https://doaj.org/article/f20213a69538401b95b48b9d61adcfe6
Autor:
Benjamin Bonsang, Laurent Maksimovic, Pascale Maille, Nadine Martin, Ingrid Laurendeau, Eric Pasmant, Ivan Bièche, Justin Deschamps, Pierre Wolkenstein, Nicolas Ortonne
Publikováno v:
Annals of diagnostic pathology. 60
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder. The role of angiogenesis and VEGF pathway in the pathogenesis of neurofibromas and malignant peripheral nerve sheath tumors (MPNSTs) remains poorly understood. We assessed the ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb2263fe78ed3132fcb4f8b651e81c54
https://pubmed.ncbi.nlm.nih.gov/35777330
https://pubmed.ncbi.nlm.nih.gov/35777330
Autor:
Paulette Bioulac Sage, Sandra Rebouissou, Valérie Paradis, Eric Letouzé, Benjamin Bonsang, Christiane Copie, Quentin Bayard, Sandrine Imbeaud, Gabrielle Couchy, Catherine Guettier, Anne de Muret, Julien Calderaro, Jean-Charles Nault, Charles Balabaud, Stefano Caruso, Jessica Zucman-Rossi, Nathalie Sturm
Publikováno v:
Gut. 69:1667-1676
BackgroundInflammatory hepatocellular adenomas (IHCAs) are benign liver tumours characterised by an activation of the janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway caused by oncogenic activating mutations. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6cb606ad69441683042414b2052ffe0
https://doi.org/10.1136/gutjnl-2019-319790
https://doi.org/10.1136/gutjnl-2019-319790
Autor:
Laurence Champion, Anissa Roger, Jerome Ghidaglia, Romain-David Seban, Benjamin Bonsang, Camille Vermersch
Publikováno v:
Diagnostics
Diagnostics, Vol 11, Iss 747, p 747 (2021)
Diagnostics, Vol 11, Iss 747, p 747 (2021)
Early detection of immune-related adverse events (irAEs) with immune checkpoint inhibitors (ICIs) is crucial, particularly when these are likely to mimic tumor progression, as well as sarcoid-like reactions. Here, we report the case of a 68-year woma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d44edf3ad820b9afe872766a572615
http://europepmc.org/articles/PMC8143543
http://europepmc.org/articles/PMC8143543
Autor:
Aurélie Montagne, Karen Leroy, Nathalie Faumont, Jean Feuillard, Jacqueline Lehmann-Che, Véronique Baud, Maria Chiara Maiuri, Hervé Tilly, Corinne Haioun, Thierry Jo Molina, Martial Caly, Davi Collares, Jean-Philippe Jais, Anne Vincent-Salomon, Christiane Copie-Bergman, J A Martinez-Climent, Stéphanie Nuan-Aliman, Didier Bordereaux, Leonardo Lordello, Bruno Tesson, Guido Kroemer, Benjamin Bonsang, Baptiste Eluard, Fabrice Jardin, Oussama Taoui, Isabelle Martins, Nicolas Cagnard
Publikováno v:
Blood. 139(3)
Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid malignancy affecting adults. The NF-κB transcription factor family is activated by 2 main pathways, the canonical and the alternative NF-κB activation pathway, with different funct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff6ed9c408fd528e6ce177771a39ed0
https://pubmed.ncbi.nlm.nih.gov/34232979
https://pubmed.ncbi.nlm.nih.gov/34232979
Autor:
Jean-François Emile, Stephanie Landowski, Elyanne Gault, Julia N'guyen Van Thanh, Pierre de Truchis, Isabelle Bourgault-Villada, Louis Jacob, Aurélie Le Gal, Jean-Louis Gaillard, Véronique Perronne, Aymeric Lanore, Nicolas Kiavue, Simon Bessis, Hélène Mascitti, Frédérique Bouchand, Aurélien Dinh, Faten El Sayed, Morgan Matt, Benjamin Davido, Valérie Sivadon-Tardy, Marie-Anne Rameix-Welti, Anne-Laure Roux, Elsa Salomon, Benjamin Bonsang, Christian Perronne, Soline Siméon, Clara Duran, Robert Carlier, Thibault Leblanc, Frédérique Moreau, Florence Assan
Publikováno v:
Open Forum Infectious Diseases
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a current pandemic worldwide. This virus can reach all organs and disturbs the immune system, leading to a cytokine storm in severe forms. We aimed to report cuta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c67fe863e6ea2b00a553fb22ecd0b87a
https://doi.org/10.1093/ofid/ofaa394
https://doi.org/10.1093/ofid/ofaa394
Autor:
Matthieu Talagas, Benjamin Bonsang, Françoise Charles, Virginie Conan-Charlet, Sandrine Guilbert, Pascale Marcorelles
Publikováno v:
Cytopathology. 30:337-339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c52202b09f4779adca90f7883a511c69
https://doi.org/10.1111/cyt.12669
https://doi.org/10.1111/cyt.12669
Autor:
Quentin, Bayard, Stefano, Caruso, Gabrielle, Couchy, Sandra, Rebouissou, Paulette, Bioulac Sage, Charles, Balabaud, Valerie, Paradis, Nathalie, Sturm, Anne, de Muret, Catherine, Guettier, Benjamin, Bonsang, Christiane, Copie, Eric, Letouzé, Julien, Calderaro, Sandrine, Imbeaud, Jean-Charles, Nault, Jessica, Zucman-Rossi
Publikováno v:
Gut. 69(9)
Inflammatory hepatocellular adenomas (IHCAs) are benign liver tumours characterised by an activation of the janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway caused by oncogenic activating mutations. However, a subs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::469f64a23c7ffd1f2546c308001ff32e
https://pubmed.ncbi.nlm.nih.gov/31907296
https://pubmed.ncbi.nlm.nih.gov/31907296
Autor:
Paolo Bénigni, Ulrike Schick, Benjamin Bonsang, Pascale Marcorelles, Arnaud Uguen, Morgan Guénolé
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 28(1)
Immune checkpoint inhibitors (ICIs) targeting the programmed cell death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) axis have revolutionized the treatment of patients with Merkel cell carcinoma (MCC). To date, no biomarker conditions access to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::235120c81589daecc9497f2f1bd3e0b3
https://pubmed.ncbi.nlm.nih.gov/31343994
https://pubmed.ncbi.nlm.nih.gov/31343994
Autor:
Romain Geiss, Anne Vincent-Salomon, Coralie Franck, Miguelle Marous, Elvire Pons Tostivint, Sophie Gardrat, Benjamin Bonsang, Céline Callens, Roman Rouzier, Guillaume Bataillon, Samia Melaabi, Nathalie Clément, Vincent Servois, P. Tresca, Choumouss Kamoun, Julien Masliah-Planchon, Ivan Bièche, Gaëlle Pierron, Elodie Girard, Odette Mariani, Claire Morel, Maud Kamal, Christophe Le Tourneau, Camille Benoist, Clémence Basse, Marie Alt, Marion Lavigne, Delphine Loirat, G Schleiermacher, Coraline Dubot, Pauline Vaflard, Marie Paule Sablin, Maude Ardin, Virginie Bernard
Publikováno v:
ESMO Open
Background High throughput molecular screening techniques allow the identification of multiple molecular alterations, some of which are actionable and can be targeted by molecularly targeted agents (MTA). We aimed at evaluating the relevance of using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::927eb97c2de2cb62282ea581714349e9
https://pubmed.ncbi.nlm.nih.gov/29636991
https://pubmed.ncbi.nlm.nih.gov/29636991